II-VI (IIVI) Getting Somewhat Favorable Press Coverage, Study Shows

Media coverage about II-VI (NASDAQ:IIVI) has been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. II-VI earned a news impact score of 0.19 on Accern’s scale. Accern also assigned media headlines about the scientific and technical instruments company an impact score of 44.7685160948458 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the media headlines that may have impacted Accern’s rankings:

How to Become a New Pot Stock Millionaire

Several equities research analysts have weighed in on the stock. Northland Securities lowered shares of II-VI from an “outperform” rating to a “market perform” rating in a report on Monday, January 22nd. BidaskClub upgraded shares of II-VI from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th. ValuEngine lowered shares of II-VI from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Zacks Investment Research upgraded shares of II-VI from a “hold” rating to a “buy” rating and set a $50.00 target price on the stock in a report on Tuesday, March 20th. Finally, B. Riley upgraded shares of II-VI from a “neutral” rating to a “buy” rating and increased their target price for the stock from $40.50 to $55.00 in a report on Tuesday, March 20th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. II-VI currently has an average rating of “Buy” and a consensus target price of $53.67.

Shares of II-VI (NASDAQ IIVI) opened at $43.00 on Monday. II-VI has a twelve month low of $27.25 and a twelve month high of $53.08. The company has a current ratio of 4.01, a quick ratio of 2.71 and a debt-to-equity ratio of 0.48. The company has a market cap of $2,686.94, a price-to-earnings ratio of 32.58, a P/E/G ratio of 1.57 and a beta of 0.12.

II-VI (NASDAQ:IIVI) last issued its quarterly earnings data on Thursday, February 1st. The scientific and technical instruments company reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.02. II-VI had a net margin of 8.08% and a return on equity of 11.10%. The business had revenue of $281.50 million for the quarter, compared to analyst estimates of $277.16 million. During the same period last year, the business posted $0.49 earnings per share. The firm’s quarterly revenue was up 21.4% on a year-over-year basis. analysts predict that II-VI will post 1.58 EPS for the current year.

In related news, CEO Vincent D. Mattera, Jr. sold 8,000 shares of the firm’s stock in a transaction on Tuesday, March 20th. The shares were sold at an average price of $47.34, for a total transaction of $378,720.00. Following the sale, the chief executive officer now directly owns 260,335 shares in the company, valued at $12,324,258.90. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.80% of the company’s stock.

WARNING: “II-VI (IIVI) Getting Somewhat Favorable Press Coverage, Study Shows” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3300904/ii-vi-iivi-getting-somewhat-favorable-press-coverage-study-shows.html.

II-VI Company Profile

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Insider Buying and Selling by Quarter for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dogecoin  Price Reaches $0.0051
Dogecoin Price Reaches $0.0051
NuBits  Trading 5% Lower  Over Last 7 Days
NuBits Trading 5% Lower Over Last 7 Days
Stratis Market Capitalization Achieves $569.21 Million
Stratis Market Capitalization Achieves $569.21 Million
Foundation Medicine  Receives Consensus Recommendation of “Hold” from Analysts
Foundation Medicine Receives Consensus Recommendation of “Hold” from Analysts
US Foods Holding Corp.  Expected to Post Earnings of $0.31 Per Share
US Foods Holding Corp. Expected to Post Earnings of $0.31 Per Share
Alexion Pharmaceuticals  Given Average Rating of “Buy” by Analysts
Alexion Pharmaceuticals Given Average Rating of “Buy” by Analysts


© 2006-2018 Ticker Report. Google+.